Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| HYPD | NASDAQ | Hyperion DeFi, Inc. | $2.51 | -4.92% | 268K | $12.53M |
| COCP | NASDAQ | Cocrystal Pharma, Inc. | $1.01 | 0.00% | 38K | $12.41M |
| COSM | NASDAQ | Cosmos Health Inc. | $0.28 | -9.31% | 4.4M | $12.41M |
| BLRX | NASDAQ | BioLineRx Ltd. | $2.82 | -1.40% | 2K | $12.27M |
| KALA | NASDAQ | KALA BIO, Inc. | $0.63 | +3.92% | 123K | $12.27M |
| DARE | NASDAQ | Dare Bioscience, Inc. | $1.28 | +1.59% | 197K | $12.19M |
| PHIO | NASDAQ | Phio Pharmaceuticals Corp. | $1.04 | -2.80% | 85K | $12.08M |
| LPCN | NASDAQ | Lipocine Inc. | $2.41 | -2.43% | 36K | $12.07M |
| HUMAW | NASDAQ | Humacyte, Inc. | $0.01 | +1.01% | 12K | $12.04M |
| INTS | NASDAQ | Intensity Therapeutics, Inc. | $4.75 | -3.06% | 3K | $12.03M |
| CALC | NASDAQ | CalciMedica, Inc. | $0.76 | +6.15% | 270K | $12M |
| LGVN | NASDAQ | Longeveron Inc. | $0.60 | -1.19% | 159K | $11.96M |
| GDTC | NASDAQ | CytoMed Therapeutics Limited | $1.03 | +5.10% | 23K | $11.71M |
| INAB | NASDAQ | IN8bio, Inc. | $1.20 | +0.84% | 30K | $11.51M |
| LFWD | NASDAQ | Lifeward Ltd. | $7.05 | +0.28% | 2K | $11.36M |
| MBRX | NASDAQ | Moleculin Biotech, Inc. | $2.12 | +1.92% | 44K | $11.31M |
| KPRX | NASDAQ | Kiora Pharmaceuticals, Inc. | $2.57 | -1.30% | 131K | $11.3M |
| XCUR | NASDAQ | Exicure, Inc. | $1.68 | +3.70% | 53K | $11.22M |
| FEMY | NASDAQ | Femasys Inc. | $3.99 | +3.64% | 35K | $11.2M |
| JSPR | NASDAQ | Jasper Therapeutics, Inc. | $0.69 | -4.26% | 668K | $11.19M |
| TVGNW | NASDAQ | Tevogen Bio Holdings Inc. | $0.05 | -2.40% | 503K | $11.03M |
| ADGM | NASDAQ | Adagio Medical Holdings, Inc. | $0.49 | +4.93% | 131K | $10.71M |
| ICU | NASDAQ | SeaStar Medical Holding Corporation | $4.00 | -5.21% | 78K | $10.64M |
| HOTH | NASDAQ | Hoth Therapeutics, Inc. | $0.88 | -3.23% | 23K | $10.64M |
| NXL | NASDAQ | Nexalin Technology, Inc. | $0.45 | -4.07% | 123K | $10.59M |
| LNAI | NASDAQ | Lunai Bioworks Inc. | $2.33 | +0.43% | 12K | $10.56M |
| OSRH | NASDAQ | OSR Holdings, Inc. | $0.33 | -0.18% | 267K | $10.39M |
| BIVI | NASDAQ | BioVie Inc. | $1.80 | +4.65% | 112K | $10.33M |
| GRDX | NASDAQ | GridAI Technologies Corp. | $3.04 | -9.25% | 257K | $10.22M |
| AKTX | NASDAQ | Akari Therapeutics, Plc | $13.50 | +0.75% | 28K | $9.96M |
| BNR | NASDAQ | Burning Rock Biotech Limited | $9.61 | +3.28% | 11 | $9.77M |
| APVO | NASDAQ | Aptevo Therapeutics Inc. | $4.15 | +5.33% | 2K | $9.6M |
| CRIS | NASDAQ | Curis, Inc. | $4.89 | +4.71% | 109K | $9.53M |
| VTGN | NASDAQ | VistaGen Therapeutics, Inc. | $0.23 | +0.18% | 1.2M | $9.29M |
| PSTV | NASDAQ | Plus Therapeutics, Inc. | $3.83 | +1.32% | 61K | $9.27M |
| BMGL | NASDAQ | Basel Medical Group Ltd Ordinary Shares | $8.12 | +26.59% | 8K | $9.06M |
| CUPR | NASDAQ | Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | $4.97 | -6.05% | 13K | $8.94M |
| WGRX | NASDAQ | Wellgistics Health, Inc. | $3.52 | 0.00% | 536K | $8.67M |
| QNRX | NASDAQ | Quoin Pharmaceuticals, Ltd. | $4.28 | -2.06% | 6K | $8.59M |
| VYNE | NASDAQ | VYNE Therapeutics Inc. | $0.71 | +7.57% | 2.9M | $8.48M |
| CMMB | NASDAQ | Chemomab Therapeutics Ltd. | $1.53 | -7.27% | 42K | $8.37M |
| MDCX | NASDAQ | Medicus Pharma Ltd. Common Stock | $0.37 | -3.70% | 1M | $8.16M |
| NCNA | NASDAQ | NuCana plc | $1.40 | +3.00% | 4K | $7.83M |
| OSRHW | NASDAQ | OSR Holdings, Inc. | $0.04 | -7.95% | 68 | $7.75M |
| MBAI | NASDAQ | Check-Cap Ltd. Ordinary Share | $1.13 | 0.00% | 16K | $7.72M |
| MDCXW | NASDAQ | Medicus Pharma Ltd. | $0.46 | +24.26% | 4 | $7.72M |
| CLRB | NASDAQ | Cellectar Biosciences, Inc. | $2.82 | +1.81% | 36K | $7.69M |
| BOLT | NASDAQ | Bolt Biotherapeutics, Inc. | $4.42 | +5.49% | 4K | $7.36M |
| PCSA | NASDAQ | Processa Pharmaceuticals, Inc. | $2.60 | -9.41% | 130K | $7.2M |
| IMRN | NASDAQ | Immuron Limited | $1.23 | -2.38% | 19K | $7.15M |